Lab
Dsi Labs ,INC
Dsi Labs ,INC was paid $843K by Medicaid between Jan 2018 and Nov 2024, across 47 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 20% of everything it billed.
33Billing provider infoDSI LABS ,INC
PONCE, PR 00717
PONCE, PR 00717
33aNPI1679828818assigned 07/13/2012
33bProvider typeClinical Medical Laboratory
28Total paid$843K
24GClaims66,431
24DCodes billed47
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#151 of 777
Median peer was paid$278K
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,576 | $92K | |
| 2019 | 5,693 | $41K | |
| 2020 | 5,435 | $58K | |
| 2021 | 9,221 | $160K | |
| 2022 | 11,196 | $221K | |
| 2023 | 12,798 | $151K | |
| 2024incomplete | 10,512 | $120K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 20% | 4,214 | 3,791 | $170K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 11% | 3,936 | 3,486 | $96K |
| 84443 | Thyroid stimulating hormone (TSH) | 10% | 5,524 | 5,200 | $87K |
| 80061 | Lipid panel | 7.7% | 5,169 | 4,883 | $65K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.5% | 9,199 | 8,517 | $63K |
| 80053 | Comprehensive metabolic panel | 6.4% | 5,489 | 5,147 | $54K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.2% | 2,203 | 1,720 | $44K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.3% | 1,319 | 1,230 | $36K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.4% | 1,345 | 1,266 | $29K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.9% | 2,711 | 2,542 | $24K |
| 36415 | Collection of venous blood by venipuncture | 2.6% | 5,355 | 4,697 | $22K |
| 86738 | 2.3% | 1,589 | 1,490 | $20K |
35 more codes
| 81000 | 2.2% | 6,059 | $19K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 334 | $17K |
| 84439 | 1.7% | 1,736 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.5% | 1,669 | $13K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 351 | $12K |
| 82274 | <1% | 558 | $8K | |
| 86328 | <1% | 348 | $7K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 176 | $7K |
| 82607 | <1% | 460 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 635 | $4K |
| 86592 | <1% | 1,048 | $4K | |
| 82043 | <1% | 837 | $4K | |
| 87088 | <1% | 622 | $4K | |
| 81001 | <1% | 977 | $3K | |
| 85730 | <1% | 350 | $2K | |
| 84153 | <1% | 113 | $2K | |
| 87205 | <1% | 363 | $1K | |
| 85610 | <1% | 376 | $1K | |
| 84436 | <1% | 200 | $1K | |
| 82947 | <1% | 222 | $798.01 | |
| 85651 | <1% | 198 | $755.01 | |
| 84479 | <1% | 117 | $657.59 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 34 | $402.25 |
| 86803 | <1% | 20 | $315.15 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 30 | $257.88 |
| 82570 | <1% | 32 | $168.64 | |
| 83655 | <1% | 13 | $151.19 | |
| 80050 | General health panel | <1% | 15 | $149.05 |
| 87186 | <1% | 36 | $139.55 | |
| 84703 | <1% | 13 | $93.31 | |
| 83540 | <1% | 13 | $84.10 | |
| 84550 | <1% | 12 | $47.18 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 21 | $0.02 |
| 3044F | 0% | 27 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 363 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSANCHEZ IRIZARRY, DAMIAN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Laboratorio Clinico Rodriguez Stella INC | Ponce, PR | $386K |
| Dsi Labs ,INC | San Juan, PR | $259K |
| Dsi Labs ,INC | San Juan, PR | $141K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.